MedTrace Logo

Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion

NCT02376127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-07-20

No results posted yet for this study

Summary

The purpose of this study is to assess imaging methods including Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) and perfusion for the cancer that has spread to the spine. The study aims to see if using these methods will help better see response to treatment with radiation in patients with spine metastases from any solid cancer.

Conditions

  • Solid Cancer
  • Metastatic Spinal Lesions

Interventions

PROCEDURE

Dynamic contrast enhancement MRI

Sponsors & Collaborators

Principal Investigators

  • Sasan Karimi, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-24
Primary Completion
2025-07-16
Completion
2025-07-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02376127 on ClinicalTrials.gov